Obesity and the risk for a hematological malignancy: leukemia, lymphoma, or myeloma
- PMID: 20930095
- PMCID: PMC3227901
- DOI: 10.1634/theoncologist.2010-0206
Obesity and the risk for a hematological malignancy: leukemia, lymphoma, or myeloma
Abstract
The aggregate of epidemiological studies indicates a significantly elevated risk for cancer in people with a high body mass index (BMI); a "dose-response" effect exists with increasing risk as BMI increases from the normal to overweight to obese categories. Successful sustained weight loss decreases future risk. The relationship of being overweight to the risk for leukemia in the aggregate has been supported in several large cohort studies and two meta-analyses of cohort and case-control studies. One meta-analysis found an elevated risk for each of the four major subtypes of leukemia. A significant association between the risk for non-Hodgkin's lymphoma and elevated BMI was supported by a meta-analysis of 13 cohort and nine case-control studies. The risk for diffuse large B-cell lymphoma may be especially significant. A high BMI increases the risk for myeloma, as judged by a meta-analysis of 11 cohort and four case-control studies. The biological relationship of obesity to the risk for cancer (biological plausibility) is unresolved. The two major causal final pathways could be "inductive" or "selective." The metabolic, endocrinologic, immunologic, and inflammatory-like changes resulting from obesity may increase the cell mutation rate, dysregulate gene function, disturb DNA repair, or induce epigenetic changes, favoring the induction of neoplastic transformation (inductive). Alternatively, obesity may create an environment in which pre-existing clones that are dormant are permitted (selected) to emerge.
Conflict of interest statement
The content of this article has been reviewed by independent peer reviewers to ensure that it is balanced, objective, and free from commercial bias. No financial relationships relevant to the content of this article have been disclosed by the independent peer reviewers.
Similar articles
-
Body size and obesity during adulthood, and risk of lympho-haematopoietic cancers: an update of the WCRF-AICR systematic review of published prospective studies.Ann Oncol. 2019 Apr 1;30(4):528-541. doi: 10.1093/annonc/mdz045. Ann Oncol. 2019. PMID: 30753270
-
Obesity and risk of non-Hodgkin's lymphoma: a meta-analysis.Int J Cancer. 2007 Oct 1;121(7):1564-70. doi: 10.1002/ijc.22762. Int J Cancer. 2007. PMID: 17443495 Review.
-
Body mass index, height, and risk of lymphatic malignancies: a prospective cohort study.Am J Epidemiol. 2009 Aug 1;170(3):297-307. doi: 10.1093/aje/kwp123. Epub 2009 May 28. Am J Epidemiol. 2009. PMID: 19478235
-
Increased incidence of non-Hodgkin lymphoma, leukemia, and myeloma in patients with diabetes mellitus type 2: a meta-analysis of observational studies.Blood. 2012 May 24;119(21):4845-50. doi: 10.1182/blood-2011-06-362830. Epub 2012 Apr 10. Blood. 2012. PMID: 22496152 Free PMC article.
-
Body Mass Index and Cancer Risk: An Umbrella Review of Meta-Analyses of Observational Studies.Nutr Cancer. 2023;75(4):1051-1064. doi: 10.1080/01635581.2023.2180824. Epub 2023 Feb 21. Nutr Cancer. 2023. PMID: 37139871
Cited by
-
Molecular mechanisms of cancer development in obesity.Nat Rev Cancer. 2011 Nov 24;11(12):886-95. doi: 10.1038/nrc3174. Nat Rev Cancer. 2011. PMID: 22113164 Review.
-
Recognizing Obesity in Adult Hospitalized Patients: A Retrospective Cohort Study Assessing Rates of Documentation and Prevalence of Obesity.J Clin Med. 2018 Aug 7;7(8):203. doi: 10.3390/jcm7080203. J Clin Med. 2018. PMID: 30087233 Free PMC article.
-
The obesity paradox in multiple myeloma: A report from Multiple Myeloma Research Foundation (MMRF) dataset.Cancer Med. 2023 Dec;12(23):21400-21407. doi: 10.1002/cam4.6685. Epub 2023 Nov 6. Cancer Med. 2023. PMID: 37930099 Free PMC article.
-
Body size and multiple myeloma mortality: a pooled analysis of 20 prospective studies.Br J Haematol. 2014 Sep;166(5):667-76. doi: 10.1111/bjh.12935. Epub 2014 May 23. Br J Haematol. 2014. PMID: 24861847 Free PMC article.
-
Lipid Level, Lipid Variability, and Risk of Multiple Myeloma: A Nationwide Population-Based Study of 3,527,776 Subjects.Cancers (Basel). 2021 Jan 31;13(3):540. doi: 10.3390/cancers13030540. Cancers (Basel). 2021. PMID: 33572660 Free PMC article.
References
-
- Centers for Disease Control and Prevention. Overweight and Obesity. [accessed June 25, 2010]. Available at http://www.cdc.gov/obesity/index.html.
-
- Flegal KM, Carroll MD, Ogden CL, et al. Prevalence and trends in obesity among US adults, 1999–2008. JAMA. 2010;303:235–241. - PubMed
-
- Roberts DL, Dive C, Renehan AG. Biological mechanisms linking obesity and cancer risk: New perspectives. Annu Rev Med. 2010;61:301–316. - PubMed
-
- Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348:1625–1638. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical